MIR587 Gene

HGNC Family Non-coding RNAs
Name microRNA 587
Description microRNAs (miRNAs) are short (20-24 nt) non-coding RNAs that are involved in post-transcriptional regulation of gene expression in multicellular organisms by affecting both the stability and translation of mRNAs. miRNAs are transcribed by RNA polymerase II as part of capped and polyadenylated primary transcripts (pri-miRNAs) that can be either protein-coding or non-coding. The primary transcript is cleaved by the Drosha ribonuclease III enzyme to produce an approximately 70-nt stem-loop precursor miRNA (pre-miRNA), which is further cleaved by the cytoplasmic Dicer ribonuclease to generate the mature miRNA and antisense miRNA star (miRNA*) products. The mature miRNA is incorporated into a RNA-induced silencing complex (RISC), which recognizes target mRNAs through imperfect base pairing with the miRNA and most commonly results in translational inhibition or destabilization of the target mRNA. The RefSeq represents the predicted microRNA stem-loop. [provided by RefSeq, Sep 2009]
Summary
{"type": "root", "children": [{"type": "p", "children": [{"type": "t", "text": "\nIn colorectal cancer, miR-587 has emerged as a key regulator of chemoresistance and metastatic behavior. Specifically, miR-587 confers resistance to 5‐fluorouracil (5‐FU)–induced apoptosis by downregulating PPP2R1B, which in turn enhances AKT phosphorylation and increases XIAP expression, thereby blunting the cytotoxic effects of chemotherapy."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "1"}]}, {"type": "t", "text": " Moreover, a circular RNA—hsa_circ_0001178—functions as a competing endogenous RNA (ceRNA) that sequesters miR-587 (along with miR-382 and miR-616) to promote ZEB1 expression and facilitate epithelial-to-mesenchymal transition, ultimately contributing to metastatic dissemination."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "2"}]}, {"type": "t", "text": "\n"}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nBeyond its roles in cancer, miR-587 also participates in metabolic regulation and adipocyte differentiation. Alterations in serum miR-587 levels have been correlated with metabolic syndrome, suggesting its potential utility as a biomarker for systemic metabolic disturbances."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "3"}]}, {"type": "t", "text": " In visceral adipose tissue, the long non-coding RNA RP11-142A22.4 modulates preadipocyte differentiation via a miR-587/Wnt5β signaling axis, where increased miR-587 expression impedes adipocyte maturation."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "4"}]}, {"type": "t", "text": "\n"}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nIn a wide spectrum of malignancies, miR-587 functions predominantly as an oncogenic factor. Aberrant miR-587 expression has been observed in hepatocellular carcinoma (HCC)"}, {"type": "fg", "children": [{"type": "fg_f", "ref": "5"}]}, {"type": "t", "text": ", and in non-small-cell lung carcinoma (NSCLC), miR-587 drives malignant cell proliferation and migration."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "6"}]}, {"type": "t", "text": " In HCC, upregulation mediated by lncRNA PANTR1 further promotes increased BCL2A1 expression and tumor progression."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "7"}]}, {"type": "t", "text": " In lung adenocarcinoma, circZMYM4 has been shown to regulate miR-587 signaling to control the expression of the tumor suppressor ODAM"}, {"type": "fg", "children": [{"type": "fg_f", "ref": "8"}]}, {"type": "t", "text": ", while in glioblastoma elevated miR-587 levels correlate with diminished tumor suppressor activity."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "9"}]}, {"type": "t", "text": " Furthermore, in epithelial ovarian cancer, overexpression of miR-587 promotes ferroptosis-related alterations that inhibit cell proliferation and migration"}, {"type": "fg", "children": [{"type": "fg_f", "ref": "10"}]}, {"type": "t", "text": ", and in bladder cancer, miR-587 overexpression enhances cell proliferation and migration via targeting SLIT3."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "11"}]}, {"type": "t", "text": " Additionally, in lung adenocarcinoma, lncRNA A2M-AS1 modulates miR-587 to influence BMP3 expression, ultimately inhibiting tumor cell growth and aggressiveness."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "12"}]}, {"type": "t", "text": "\n"}]}, {"type": "rg", "children": [{"type": "r", "ref": 1, "children": [{"type": "t", "text": "Yang Zhang, G Talmon, J Wang "}, {"type": "b", "children": [{"type": "t", "text": "MicroRNA-587 antagonizes 5-FU-induced apoptosis and confers drug resistance by regulating PPP2R1B expression in colorectal cancer."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cell Death Dis (2015)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/cddis.2015.200"}], "href": "https://doi.org/10.1038/cddis.2015.200"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "26247730"}], "href": "https://pubmed.ncbi.nlm.nih.gov/26247730"}]}, {"type": "r", "ref": 2, "children": [{"type": "t", "text": "Chunfeng Ren, Zhenmin Zhang, Shunhua Wang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Circular RNA hsa_circ_0001178 facilitates the invasion and metastasis of colorectal cancer through upregulating ZEB1 via sponging multiple miRNAs."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Biol Chem (2020)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1515/hsz-2019-0350"}], "href": "https://doi.org/10.1515/hsz-2019-0350"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "31747371"}], "href": "https://pubmed.ncbi.nlm.nih.gov/31747371"}]}, {"type": "r", "ref": 3, "children": [{"type": "t", "text": "Jun Guo, Yajun Lin, Jie Wei, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Diagnostic Value of Serum MiR-587 in Patients with Metabolic Syndrome."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Clin Lab (2019)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.7754/Clin.Lab.2019.181253"}], "href": "https://doi.org/10.7754/Clin.Lab.2019.181253"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "31307169"}], "href": "https://pubmed.ncbi.nlm.nih.gov/31307169"}]}, {"type": "r", "ref": 4, "children": [{"type": "t", "text": "Tongtong Zhang, Hongtao Liu, Rui Mao, et al. "}, {"type": "b", "children": [{"type": "t", "text": "The lncRNA RP11-142A22.4 promotes adipogenesis by sponging miR-587 to modulate Wnt5β expression."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cell Death Dis (2020)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/s41419-020-2550-9"}], "href": "https://doi.org/10.1038/s41419-020-2550-9"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "32561739"}], "href": "https://pubmed.ncbi.nlm.nih.gov/32561739"}]}, {"type": "r", "ref": 5, "children": [{"type": "t", "text": "Miao Chen, Duo Wang, Junjie Liu, et al. "}, {"type": "b", "children": [{"type": "a", "children": [{"type": "t", "text": "i"}], "href": "i"}, {"type": "t", "text": "MicroRNA-587"}, {"type": "a", "children": [{"type": "t", "text": "/i"}], "href": "/i"}, {"type": "t", "text": " Functions as a Tumor Suppressor in Hepatocellular Carcinoma by Targeting Ribosomal Protein SA."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Biomed Res Int (2020)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1155/2020/3280530"}], "href": "https://doi.org/10.1155/2020/3280530"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "32964027"}], "href": "https://pubmed.ncbi.nlm.nih.gov/32964027"}]}, {"type": "r", "ref": 6, "children": [{"type": "t", "text": "X-J Li, L-W Chen, P Gao, et al. "}, {"type": "b", "children": [{"type": "t", "text": "MiR-587 acts as an oncogene in non-small-cell lung carcinoma via reducing CYLD expression."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Eur Rev Med Pharmacol Sci (2020)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.26355/eurrev_202012_24173"}], "href": "https://doi.org/10.26355/eurrev_202012_24173"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "33378022"}], "href": "https://pubmed.ncbi.nlm.nih.gov/33378022"}]}, {"type": "r", "ref": 7, "children": [{"type": "t", "text": "Xirui Ma, Ziming Mao, Jing Zhu, et al. "}, {"type": "b", "children": [{"type": "t", "text": "lncRNA PANTR1 Upregulates BCL2A1 Expression to Promote Tumorigenesis and Warburg Effect of Hepatocellular Carcinoma through Restraining miR-587."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Immunol Res (2021)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1155/2021/1736819"}], "href": "https://doi.org/10.1155/2021/1736819"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "34423048"}], "href": "https://pubmed.ncbi.nlm.nih.gov/34423048"}]}, {"type": "r", "ref": 8, "children": [{"type": "t", "text": "Dong-Feng Yuan, Hao-Ran Wang, Zong-Fei Wang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "CircRNA CircZMYM4 inhibits the growth and metastasis of lung adenocarcinoma via the miR-587/ODAM pathway."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Biochem Biophys Res Commun (2021)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.bbrc.2021.09.085"}], "href": "https://doi.org/10.1016/j.bbrc.2021.09.085"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "34634673"}], "href": "https://pubmed.ncbi.nlm.nih.gov/34634673"}]}, {"type": "r", "ref": 9, "children": [{"type": "t", "text": "Kun Lin, Shang-Hang Shen, Feng Lu, et al. "}, {"type": "b", "children": [{"type": "t", "text": "CRISPR screening of E3 ubiquitin ligases reveals Ring Finger Protein 185 as a novel tumor suppressor in glioblastoma repressed by promoter hypermethylation and miR-587."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Transl Med (2022)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1186/s12967-022-03284-z"}], "href": "https://doi.org/10.1186/s12967-022-03284-z"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "35183197"}], "href": "https://pubmed.ncbi.nlm.nih.gov/35183197"}]}, {"type": "r", "ref": 10, "children": [{"type": "t", "text": "Li Cai, Xiaoqing Hu, Lu Ye, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Long non-coding RNA ADAMTS9-AS1 attenuates ferroptosis by Targeting microRNA-587/solute carrier family 7 member 11 axis in epithelial ovarian cancer."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Bioengineered (2022)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1080/21655979.2022.2049470"}], "href": "https://doi.org/10.1080/21655979.2022.2049470"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "35311457"}], "href": "https://pubmed.ncbi.nlm.nih.gov/35311457"}]}, {"type": "r", "ref": 11, "children": [{"type": "t", "text": "Xiaoyu Duan, Lingdian Wang, Zhifeng Wang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "LncRNA PGM5-AS1 Inhibits the Progression of Bladder Cancer by Regulating miR-587/SLIT3 Axis."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Crit Rev Eukaryot Gene Expr (2022)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1615/CritRevEukaryotGeneExpr.2022042376"}], "href": "https://doi.org/10.1615/CritRevEukaryotGeneExpr.2022042376"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "36017912"}], "href": "https://pubmed.ncbi.nlm.nih.gov/36017912"}]}, {"type": "r", "ref": 12, "children": [{"type": "t", "text": "Hongfei Guo, Tao Li, Chunlei Peng, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Overexpression of lncRNA A2M-AS1 inhibits cell growth and aggressiveness "}, {"type": "a", "children": [{"type": "t", "text": "i"}], "href": "i"}, {"type": "t", "text": "via"}, {"type": "a", "children": [{"type": "t", "text": "/i"}], "href": "/i"}, {"type": "t", "text": " regulating the miR-587/bone morphogenetic protein 3 axis in lung adenocarcinoma."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Hum Exp Toxicol (2022)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1177/09603271221138971"}], "href": "https://doi.org/10.1177/09603271221138971"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "36461613"}], "href": "https://pubmed.ncbi.nlm.nih.gov/36461613"}]}]}]}
Synonyms HSA-MIR-587, MIRN587
NCBI Gene ID 693172
API
Download Associations
Predicted Functions View MIR587's ARCHS4 Predicted Functions.
Co-expressed Genes View MIR587's ARCHS4 Predicted Functions.
Expression in Tissues and Cell Lines View MIR587's ARCHS4 Predicted Functions.

Functional Associations

MIR587 has 96 functional associations with biological entities spanning 1 categories (cell line, cell type or tissue) extracted from 1 datasets.

Click the + buttons to view associations for MIR587 from the datasets below.

If available, associations are ranked by standardized value

Dataset Summary
Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene CNV Profiles cell lines with high or low copy number of MIR587 gene relative to other cell lines from the Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene CNV Profiles dataset.